Mesothelioma News

Canada to Keep Asbestos off Trade Blacklist - Wed, 05 Nov 2008

Source: The Guardian

A coalition made up of Canada and a number of developing countries has successfully lobbied to keep chrysotile asbestos from being added to the Rotterdam Convention’s list of hazardous substances...

Report On Vermiculite Asbestos Exposure - Wed, 05 Nov 2008

Source: UPI.com

The Agency for Toxic Substances and Disease Registry (ATSDR) has released its anticipated report on asbestos-contaminated vermiculite from Libby, Montana...

Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma - Tue, 21 Oct 2008

Source: Journal of Thoracic Oncology

The development of truly curative therapeutic approaches for the treatment of mesothelioma is the “Holy Grail” of contemporary research into malignant mesothelioma...

Preoperative Staging of Mesothelioma by 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Fused Imaging - Fri, 17 Oct 2008

Source: European Journal of Cardio-Thoracic Surgery

Full Title: Preoperative Staging of Mesothelioma by 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Fused Imaging and Mediastinoscopy Compared to Pathological Findings After Extrapleural Pneumonectomy

Disease staging is one of the fundamental steps in the development of a treatment plan for patients with mesothelioma...

The Impact of Lymph Node Station on Survival in 348 Patients with Surgically Resected Malignant Pleural Mesothelioma - Wed, 15 Oct 2008

Source: The Journal of Thoracic and Cardiovascular Surgery

Full Title: The Impact of Lymph Node Station on Survival in 348 Patients with Surgically Resected Malignant Pleural Mesothelioma: Implications for Revision of the American Joint Committee on Cancer Staging System

The current system for staging cases of pleural mesothelioma is based on a TNM model, where the determination of disease stage is based on the relationship between tumor status (T stage), lymph node status (N stage) and the presence or absence of distant metastases (M stage)...

Metastasis of Malignant Peritoneal Epithelioid Mesothelioma in Endoscopic Gastric Biopsy: A Diagnostic Pitfall - Tue, 14 Oct 2008

Source: International Journal of Surgical Pathology

Peritoneal mesothelioma is the second most common form of mesothelioma, appearing in 20% of all cases...

Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA - Mon, 13 Oct 2008

Source: International Business Times

ONCONASE is a first-in-class antitumor agent developed by Alfacell that has shown efficacy for the second-line treatment of malignant mesothelioma...

Pleural Fluid Findings as Prognostic Factors for Malignant Pleural Mesothelioma - Fri, 10 Oct 2008

Source: Journal of Clinical Laboratory Analysis

Advances in our ability to diagnose mesothelioma in its earlier stages are among the most important developments in the recent fight against the disease...

Treatment of Peritoneal Mesothelioma in Pediatric Patients - Thu, 09 Oct 2008

Source: Pediatric Blood & Cancer

Malignant Mesothelioma is most commonly a disease of the older and the elderly...

Enhanced Antitumor Therapy by Inhibition of P21 in Human Malignant Mesothelioma - Wed, 08 Oct 2008

Source: Clinical Cancer Research

Even as the introduction of combination chemotherapy using pemetrexed and cisplatin(Alimta Therapy) was a watershed event in the history of mesothelioma treatments, research into the disease’s underlying cellular activity has shown that mesothelioma cells demonstrate a natural resistance to most forms of chemotherapy, as well as a natural resistance to apoptosis...

Mesothelioma News Archive: Past Headlines

• Lilly says FDA widens use of cancer drug Alimta - Wed, 01 Oct 2008
• Systemic Treatments for Mesothelioma: Standard and Novel - Tue, 30 Sep 2008
• Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Unresectable or Metastatic Malignant Mesothelioma - Wed, 24 Sep 2008
• Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma - Tue, 23 Sep 2008
• Mesothelioma Articles in Current Treatment Options in Oncology - Mon, 22 Sep 2008
• Consensus Statement on Peritoneal Mesothelioma - Fri, 19 Sep 2008
• MVP and Vinorelbine for Malignant Pleural Mesothelioma - Thu, 18 Sep 2008
• Prevention of Malignant Seeding at Drain Sites after Invasive Procedures ... by Hypofractionated Radiotherapy in Patients with Pleural Mesothelioma - Wed, 17 Sep 2008
• Successful Palliation of Malignant Ascites from Peritoneal Mesothelioma by Laparoscopic Intraperitoneal Hyperthermic Chemotherapy - Tue, 16 Sep 2008
• Review of Pemetrexed in Combination with Cisplatin for the Treatment of Malignant Pleural Mesothelioma - Mon, 15 Sep 2008
• Molmed gets US FDA Orphan Drug Status for Malignant Mesothelioma Drug - Wed, 03 Sep 2008
• Localized Malignant Mesothelioma in the Middle Mediastinum: Report of a Case - Tue, 02 Sep 2008
• Incidence of Atrial Fibrillation after Extrapleural Pneumonectomy versus Pleurectomy in patients with Malignant Pleural Mesothelioma - Fri, 29 Aug 2008
• Pemetrexed plus Gemcitabine as First-Line Chemotherapy for Patients with Peritoneal Mesothelioma: Final Report of a Phase II Trial - Wed, 27 Aug 2008
• Prevalence and Pattern of Lymph Node Metastasis in Malignant Pleural Mesothelioma - Mon, 25 Aug 2008